why choose us

First received: March 22, 2023

Clinical Trial: Metformin Treatment on Cognitive Impairment of Schizophrenia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial

Brief Summary: In this study, the investigators will investigate the effect and the underlying mechanism of metformin treatment on cognitive impairment in individuals with schizophrenia. The study will recruit 120 individuals with schizophrenia at 4 sites, who will be randomized to metformin or placebo group for 24-week treatment. Clinical assessments will be done at screen/baseline, 12th week and 24th week. Participants who don't meet any of the diagnostic criteria for metabolic syndrome will only accept baseline evaluations.…

Read more